article

Drug Targets In-Depth Focus 2012

Posted: 11 December 2012 | | No comments yet

In this Drug Targets In-Depth Focus: GPCR allosteric modulation: new opportunities and challenges for drug discovery; Chloride channels and cardiac arrhythmia: novel therapeutic targets?

Drug Targets In-Depth Focus 2012
  • GPCR allosteric modulation: new opportunities and challenges for drug discovery
    Patricia McDonald, Associate Scientific Director of Discovery Biology & Emmanuel Sturchler, Senior Scientist, Translational Research Institute, Scripps Florida
  • Chloride channels and cardiac arrhythmia: novel therapeutic targets?
    Dayue Darrel Duan, Laboratory of Cardiovascular Phenomics, the Department of Pharmacology, University of Nevada School of Medicine and colleagues

This Drug Targets In-Depth Focus is restricted - login or subscribe free to access

European Pharmaceutical Review Issue 3 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here